|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.05 SEK | -3.44% |
|
+2.55% | +76.73% |
| 04-25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 01-29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Arcoma AB reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 163.02 million compared to SEK 125.05 million a year ago. Revenue was SEK 165.99 million compared to SEK 129.88 million a year ago.
Net income was SEK 2.56 million compared to SEK 1.9 million a year ago. Basic earnings per share from continuing operations was SEK 0.19.
| 1st Jan change | Capi. | |
|---|---|---|
| +76.73% | 17.69M | |
| -0.97% | 15.26B | |
| -36.20% | 3.01B | |
| -12.03% | 2.44B | |
| -12.41% | 1.46B | |
| -.--% | 1.12B | |
| +63.74% | 591M | |
| +14.60% | 247M | |
| -2.35% | 231M | |
| +7.96% | 194M |
ARCOMA AB 
